To determine whether tankyrase inhibitors interrupt the parsylation-mediated process for destabilizing AXIN protein levels, HCC cells were treated with XAV939 or WXL-8 at 10 μM, and AXIN1 and AXIN2 protein levels were detected by immunoblotting. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.